LENZ Therapeutics (LENZ) Inventory Average (2022 - 2026)

LENZ Therapeutics (LENZ) has 4 years of Inventory Average data on file, last reported at $3.2 million in Q1 2026.

• Quarterly Inventory Average changed N/A year-over-year to $3.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.2 million (changed N/A YoY) and the FY2022 annual result came in at $2.2 million, up 54.84% from the prior year.
• Inventory Average climbed to $3.2 million in Q1 2026 per LENZ's latest filing, from $1.9 million in the prior quarter.
• Across five years, Inventory Average topped out at $3.2 million in Q1 2026 and bottomed at $1.1 million in Q2 2023.
• The 4-year median for Inventory Average is $2.0 million (2022), against an average of $2.1 million.
• Peak annual rise in Inventory Average reached 29.71% in 2023, while the deepest fall reached 37.33% in 2023.
• Tracing LENZ's Inventory Average over 4 years: stood at $2.5 million in 2022, then tumbled by 57.54% to $1.1 million in 2023, then surged by 84.82% to $1.9 million in 2025, then soared by 65.61% to $3.2 million in 2026.
• Per Business Quant, the three latest LENZ Inventory Average figures stand at $3.2 million (Q1 2026), $1.9 million (Q4 2025), and $1.1 million (Q2 2023).

Peer Comparison